Infectious disease
Vaccinia virus Copenhagen Protein G5 18-26 (HLA-A*02:01) ILDDNLYKV
Product number: EP11450_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
ILDDNLYKV is a linear peptidic epitope (epitope ID26990) studied as part of Putative nuclease G5 from Vaccinia virus and Putative nuclease G5 from Variola virus (smallpox virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
TechData
| Sequence: | ILDDNLYKV |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Vaccinia virus Copenhagen Protein G5 |
| Species: | Vaccinia virus (VACV) |
| Allele: | HLA-A*02:01 |
| Indication: | Infectious disease, Cancer |
| Purity: | 95% HPLC-MS |